• Explore /
  • Poster
  • / A multicenter phase II trial of mFOLFOX6 plus bevacizumab as treatment for liver-only metastases from colorectal cancer unsuitable for upfront resection (TRICC 0808).

A multicenter phase II trial of mFOLFOX6 plus bevacizumab as treatment for liver-only metastases from colorectal cancer unsuitable for upfront resection (TRICC 0808).

Abstract Poster

Authors

null

Hiroyuki Uetake

Department of Translational Oncology, Tokyo Medica

Hiroyuki Uetake , Masamichi Yasuno , Megumi Ishiguro , Shingo Kameoka , Yasuhiro Shimada , Keiichi Takahashi , Toshiaki Watanabe , Kei Muro , Hideo Baba , Junji Yamamoto , Nobuyuki Mizunuma , Hiroshi Tamagawa , Izumi Mochizuki , Yusuke Kinugasa , Yoshihiro Matsubara , Kenichi Sugihara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000002101

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr543)

DOI

10.1200/jco.2013.31.4_suppl.543

Abstract #

543

Poster Bd #

D43

Abstract Disclosures

Similar Posters

First Author: Hiroshi Tamagawa

First Author: Qi Lin

First Author: Thomas Jens Ettrich

First Author: Syu Tanimura